CRDE
Price
$15500.00
Change
-$1800.00 (-10.40%)
Updated
Dec 23 closing price
Capitalization
316.59M
ECSNF
Price
$2.79
Change
-$1.09 (-28.09%)
Updated
Jan 10 closing price
Capitalization
172.46M
Ad is loading...

CRDE vs ECSNF

Header iconCRDE vs ECSNF Comparison
Open Charts CRDE vs ECSNFBanner chart's image
Cardinal Ethanol
Price$15500.00
Change-$1800.00 (-10.40%)
Volume$1
Capitalization316.59M
Ecosynthetix
Price$2.79
Change-$1.09 (-28.09%)
Volume$2.15K
Capitalization172.46M
CRDE vs ECSNF Comparison Chart
Loading...
CRDE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDE vs. ECSNF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDE is a Hold and ECSNF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CRDE: $15500.00 vs. ECSNF: $2.79)
Brand notoriety: CRDE and ECSNF are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: CRDE: 14% vs. ECSNF: 566%
Market capitalization -- CRDE: $316.59M vs. ECSNF: $172.46M
CRDE [@Chemicals: Specialty] is valued at $316.59M. ECSNF’s [@Chemicals: Specialty] market capitalization is $172.46M. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $223.16B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDE’s FA Score shows that 2 FA rating(s) are green whileECSNF’s FA Score has 0 green FA rating(s).

  • CRDE’s FA Score: 2 green, 3 red.
  • ECSNF’s FA Score: 0 green, 5 red.
According to our system of comparison, CRDE is a better buy in the long-term than ECSNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDE’s TA Score shows that 3 TA indicator(s) are bullish.

  • CRDE’s TA Score: 3 bullish, 3 bearish.

Price Growth

CRDE (@Chemicals: Specialty) experienced а 0.00% price change this week, while ECSNF (@Chemicals: Specialty) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +3.41%. For the same industry, the average monthly price growth was +3.38%, and the average quarterly price growth was -4.22%.

Industries' Descriptions

@Chemicals: Specialty (+3.41% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDE($317M) has a higher market cap than ECSNF($172M). CRDE YTD gains are higher at: 0.000 vs. ECSNF (-28.093). CRDE has higher annual earnings (EBITDA): 67.7M vs. ECSNF (-2.06M). CRDE has more cash in the bank: 89.9M vs. ECSNF (35.6M). ECSNF has less debt than CRDE: ECSNF (787K) vs CRDE (39.7M). CRDE has higher revenues than ECSNF: CRDE (437M) vs ECSNF (17.9M).
CRDEECSNFCRDE / ECSNF
Capitalization317M172M184%
EBITDA67.7M-2.06M-3,289%
Gain YTD0.000-28.093-
P/E Ratio5.59N/A-
Revenue437M17.9M2,441%
Total Cash89.9M35.6M253%
Total Debt39.7M787K5,044%
FUNDAMENTALS RATINGS
CRDE vs ECSNF: Fundamental Ratings
CRDE
ECSNF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
1974
SMR RATING
1..100
4791
PRICE GROWTH RATING
1..100
8388
P/E GROWTH RATING
1..100
33100
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRDE's Valuation (46) in the null industry is somewhat better than the same rating for ECSNF (79). This means that CRDE’s stock grew somewhat faster than ECSNF’s over the last 12 months.

CRDE's Profit vs Risk Rating (19) in the null industry is somewhat better than the same rating for ECSNF (74). This means that CRDE’s stock grew somewhat faster than ECSNF’s over the last 12 months.

CRDE's SMR Rating (47) in the null industry is somewhat better than the same rating for ECSNF (91). This means that CRDE’s stock grew somewhat faster than ECSNF’s over the last 12 months.

CRDE's Price Growth Rating (83) in the null industry is in the same range as ECSNF (88). This means that CRDE’s stock grew similarly to ECSNF’s over the last 12 months.

CRDE's P/E Growth Rating (33) in the null industry is significantly better than the same rating for ECSNF (100). This means that CRDE’s stock grew significantly faster than ECSNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDEECSNF
RSI
ODDS (%)
Bullish Trend 12 days ago
13%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
26%
N/A
Momentum
ODDS (%)
Bullish Trend 12 days ago
6%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
40%
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
24%
Bullish Trend 12 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
20%
Bullish Trend 12 days ago
43%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CRDE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRCE3.660.30
+8.93%
Grace Therapeutics Inc
TLS3.310.05
+1.53%
Telos Corp
TDW55.700.33
+0.60%
Tidewater
GEHC84.74-0.26
-0.31%
GE HealthCare Technologies
OCUL8.01-0.04
-0.50%
Ocular Therapeutix

CRDE and

Correlation & Price change

A.I.dvisor tells us that CRDE and ECL have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDE and ECL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDE
1D Price
Change %
CRDE100%
N/A
ECL - CRDE
24%
Poorly correlated
-0.72%
DLNDY - CRDE
10%
Poorly correlated
+12.33%
DTPKF - CRDE
4%
Poorly correlated
N/A
CSNVY - CRDE
1%
Poorly correlated
N/A
CSNVF - CRDE
0%
Poorly correlated
N/A
More

ECSNF and

Correlation & Price change

A.I.dvisor tells us that ECSNF and NDEKY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECSNF and NDEKY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECSNF
1D Price
Change %
ECSNF100%
N/A
NDEKY - ECSNF
20%
Poorly correlated
+0.53%
NDEKF - ECSNF
20%
Poorly correlated
-1.45%
DLNDY - ECSNF
10%
Poorly correlated
+12.33%
CSNVY - ECSNF
4%
Poorly correlated
N/A
CRDE - ECSNF
0%
Poorly correlated
N/A
More